Clearside Biomedical, Inc. (NASDAQ:CLSD), currently valued at $81.15 million, is a biotechnology company focused on developing innovative therapies for blinding eye diseases using its proprietary SCS ...

Nishit Agarwal exemplifies excellence in Biomedical AI and Signal Processing with extensive experience in developing ...

"Large language models hold immense potential to transform biomedical research by making complex data and analysis tasks more accessible," said Julio Saez-Rodriguez, Head of Research at EMBL's ...

Our programs encompass both biomedical research and clinical care informatics with ... multiple disciplines and will be of interest if you seek a career in which you: Analyze patient diagnoses, ...

Mr. Dawes will be joined at the conference by Dr. Rachel Brem, board member and part-time Chief Medical Officer, and Jean Nadeau, Chairman. Centurion One Capital 8th Annual Growth Conference ...

The 36-week trial was a randomized, double-masked, parallel-group, active-controlled, multicenter evaluating CLS-AX (axitinib ...